TNFRSF9 and infection: Patients with HM had a significant rise (P = .02) in the frequency of spike-specific activated CD134+CD137+CD4+ T cells post–BT infection (Figure 3D) but not spike-specific activated CD69+CD137+CD8+ T cells (P = .77; Figure 3D).